GlassScriptPhysician profile
Keith Liang
NPI 1043304280
$51,245.25
in general payments reported to CMS, 2019-2025
29 companies · $616 in 2025
The $616 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,594 · 2020: $305 · 2021: $2,059 · 2022: $861 · 2023: $45K · 2024: $700 · 2025: $616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $43K · Food and Beverage: $3,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $43,300.15 |
| Food and Beverage | $3,126.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $43,341.53 | 2021-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Lensar, INC. | $1,434.13 | 2019-2024 | Lensar Laser System |
| Carl Zeiss Meditec, INC. | $1,396.51 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $987.51 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $975.95 | 2022-2025 | Stellaris, Envista Mx60 Iol, Scoutpro Osmolarity System |
| Abbvie INC. | $883.12 | 2019-2025 | |
| Allergan, INC. | $257.37 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $226.50 | 2019-2021 | |
| New World Medical,INC. | $199.13 | 2024-2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Alcon Vision LLC | $183.18 | 2019-2025 | Clareon Panoptix Pro, Rocklatan, Clareon |
| Dompe US, INC. | $159.11 | 2019-2025 | Oxervate |
| Genentech USA, INC. | $150.00 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $144.69 | 2022 | |
| Beaver-Visitec International, INC. | $141.29 | 2019 | |
| Oyster Point Pharma, INC. | $127.75 | 2022-2024 | Tyrvaya |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumibird Medical INC. | $91.58 | 2025 | |
| Eyevance Pharmaceuticals LLC | $74.94 | 2019-2022 | |
| Biotissue Holdings INC. | $66.82 | 2020-2025 | |
| Mallinckrodt Hospital Products INC. | $66.44 | 2021-2023 | Acthar |
| Thea Pharma INC. | $56.74 | 2023-2024 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $54.00 | 2021-2023 | Tecnis Iol |
| Rayner Intraocular Lenses Limited | $46.29 | 2023-2024 | Omidria, Rayone Emv, Rayone Aspheric |
| Novartis Pharmaceuticals Corporation | $41.37 | 2019 | |
| Sight Sciences, INC. | $33.67 | 2021-2022 | |
| Harrow Eye, LLC | $26.60 | 2024 | Iheezo |
| Iridex Corporation | $22.28 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $20.11 | 2025 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kala Pharmaceuticals, INC. | $17.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.